Allogene Therapeutics ALLO Slides 378 as Biotech Sector Faces Pressure SpaceX Faces Investor Scrutiny After Musk Comments on Anthropic Deal Differ from IPO Filing ZOOZ Q2 2025 Earnings EPS Misses Estimates as Losses Widen Stock Gains 5 Kalshi Traders Bet on IonQ Micron and Anduril as Next Potential US Government Stake Targets